Australia · SciencePreventive health care: what the evidence shows

Australia · Science

Preventive health care: what the evidence shows

Preventive health care covers screening, risk checks and falls prevention. Here's what the evidence shows, and where it runs out.


Preventive health care means checking for health risks and early disease before symptoms appear, from heart and diabetes risk factors to depression screening and falls prevention in older age [1][2][4][6]. The evidence is strongest for some of these checks and still developing for others, including newer longevity-focused approaches [5].

What is preventive health care?

Preventive health care covers the checks, tests and habits used to find risk factors or disease early, before they cause symptoms, rather than treating illness after it appears [1]. It spans several areas: cardiovascular risk factors such as blood pressure and cholesterol, which contribute to the world's leading cause of death [1]; diabetes diagnosis and classification, which has standardised clinical criteria reviewed every year [2][3]; falls prevention programs for older adults living in the community [4]; and mental health screening tools such as the PHQ-9 questionnaire for depression [6]. A newer and still experimental strand looks at ageing biology itself, including drug pathways such as mTOR (a cell pathway that helps control growth and metabolism) that influence lifespan in laboratory models [5].

How does preventive health care work in practice?

In practice, preventive health care works through standardised checks, questionnaires and, in some cases, structured programs rather than a single test. Each domain has its own method.

Cardiovascular and metabolic checks

Heart disease and diabetes are assessed using known risk factors and diagnostic criteria rather than one blood test. Cardiovascular disease is tracked globally through risk factors and underlying causes of death, and the burden has grown substantially: prevalent cases nearly doubled from 271 million in 1990 to 523 million in 2019, while global deaths from cardiovascular disease rose from 12.1 million to 18.6 million over the same period [1]. Diabetes is diagnosed and classified using standards set out by the American Diabetes Association, which are reviewed and updated annually [2][3].

Falls prevention programs

For older adults, prevention often means a structured program rather than a single test. About 30% of people over 65 living in the community fall each year, and Cochrane reviewers pooled data from 159 trials involving 79,193 participants to work out which interventions change that rate [4].

Mental health screening

Depression screening commonly uses short questionnaires such as the PHQ-9, a nine item tool whose accuracy has been tested against clinical diagnostic interviews across dozens of studies [6].

What does the evidence show?

The strength of evidence differs a lot depending on which part of preventive health care you're asking about. For falls prevention, the evidence base is large and consistent: the Cochrane review pooled many trial designs and measured changes in the rate of falls and the risk of falling across the included studies [4]. For depression screening, evidence comes from an individual participant data meta-analysis, a strong study design that recalculates accuracy using the original data from dozens of studies, and it confirms the PHQ-9 performs differently depending on the cut-off score and the type of diagnostic interview used for comparison [6]. For diabetes, the evidence underpinning diagnosis and classification is reviewed and graded by an expert panel every year, which is why the criteria can shift from one year to the next [2][3]. For cardiovascular disease, the evidence is mostly about scale and trend rather than a single intervention: the Global Burden of Disease study shows the size and direction of the problem worldwide, which is why cardiovascular risk factors remain a central target of preventive checks [1]. The newest area, pharmacological ageing science, is the least mature for humans: mTOR inhibition extends lifespan and reduces age-related disease in model organisms, and some mTOR-targeting drugs are already approved for other medical uses, but side effects currently rule out their use in healthy people purely to slow ageing [5].

Who might preventive health care suit?

Preventive health care is broad, so who it suits depends on the specific check or program. Falls prevention programs are aimed at community-dwelling older adults, particularly those over 65, since this is the group in whom the trial evidence was gathered [4]. Cardiovascular and diabetes checks matter across most of adult life because both conditions are major, growing contributors to the global disease burden and often develop silently over years [1][2][3]. Depression screening with tools like the PHQ-9 is used broadly in general practice because it's a short, low-burden tool rather than one that requires a specialist interview [6]. Longevity-focused drug interventions, by contrast, are not currently supported by evidence for healthy adults outside clinical research, given the side-effect profile described above [5].

What are the risks and limits of preventive health care?

No preventive check is without trade-offs, and evidence varies by condition and by protocol. Screening tools involve a balance between sensitivity (correctly identifying people who have the condition) and specificity (correctly ruling out those who don't), and the PHQ-9 meta-analysis found this balance shifts depending on the cut-off score chosen, so some thresholds miss more cases while others flag more people who don't actually have major depression [6]. Falls prevention trials form a large and mixed evidence base of 159 studies, and programs need to be matched to a person's actual risk factors rather than applied as one generic solution, which is part of why Cochrane reviewers analysed multiple intervention types separately [4]. Diabetes diagnostic criteria are revised regularly by expert committees, which means guidance can change from year to year as new evidence comes in [2][3]. The clearest caution is around ageing-focused pharmacology: mTOR-pathway drugs show lifespan and disease benefits in laboratory animals, but the same research notes adverse side effects currently preclude their use in otherwise healthy people, so this remains an area for clinical research rather than routine preventive care [5].

Key takeaways

  • Preventive health care spans cardiovascular and diabetes risk checks, falls prevention, mental health screening and, more experimentally, ageing biology [1][2][3][4][5][6].
  • Evidence is strongest where trial bases are large, such as falls prevention, with 159 trials and 79,193 participants [4].
  • Screening tools like the PHQ-9 trade off sensitivity and specificity depending on cut-off score, so no single threshold is perfect [6].
  • Drugs targeting ageing pathways like mTOR show promise in animal models but are not yet appropriate for healthy people due to side effects [5].
  • Cardiovascular disease and diabetes remain major, growing global health burdens, which is why they sit at the centre of preventive checks across adulthood [1][2][3].

Frequently asked questions

Does preventive health care reduce falls in older adults?

Trial evidence pooled by Cochrane reviewers, covering 159 trials and 79,193 participants, looked specifically at whether interventions change the rate of falls or the risk of falling among people over 65 living in the community [4]. This is one of the larger evidence bases in preventive health care, though effectiveness depends on which intervention and which population group [4].

Can a questionnaire reliably detect depression?

The PHQ-9 questionnaire has been tested in an individual participant data meta-analysis against clinical diagnostic interviews, and its accuracy changes depending on the cut-off score used and the type of interview it's compared against [6]. This makes it a useful screening tool, but not a stand-alone diagnosis [6].

Are anti-ageing drugs available for healthy people right now?

Not currently as a preventive option: mTOR-pathway drugs extend lifespan and reduce age-related disease in laboratory models, and some are already approved for other uses, but adverse side effects currently preclude their use in otherwise healthy people [5].

Why do heart disease and diabetes feature so heavily in preventive care?

Cardiovascular disease is the leading cause of death globally, with cases nearly doubling between 1990 and 2019, and diabetes has standardised, regularly updated diagnostic criteria, which is part of why both are central targets of routine preventive checks [1][2][3].

This article is for informational purposes and is not medical advice.

References

[1] Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study (2020). https://doi.org/10.1016/j.jacc.2020.11.010

[2] 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023 (2023). https://doi.org/10.2337/dc23-s002

[3] 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes-2024 (2024). https://doi.org/10.2337/dc24-s002

[4] Interventions for preventing falls in older people living in the community (2012). https://doi.org/10.1002/14651858.cd007146.pub3

[5] mTOR is a key modulator of ageing and age-related disease (2013). https://doi.org/10.1038/nature11861

[6] Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis (2019). https://doi.org/10.1136/bmj.l1476

Every claim on variis is sourced and evidence-graded. Not medical advice.